Veracyte Inc stock is traded at $23.95, with a volume of 146,163. It is down -1.56% in the last 24 hours and down -44.46% over the past month. Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
Previous Close:
$24.33
Open:
$23.97
24h Volume:
146,163
Relative Volume:
0.03
Market Cap:
$1.93B
Revenue:
$541.74M
Net Income/Loss:
$88.01M
P/E Ratio:
22.05
EPS:
$1.09
Net Cash Flow:
$155.34M
1W Performance:
-7.60%
1M Performance:
-44.46%
6M Performance:
-37.76%
1Y Performance:
-39.14%
1-Day Range:
$23.27$24.10
1-Week Range:
$23.27$25.88
52-Week Range:
$21.91$60.91
Veracyte Inc Stock (VCYT) Company Profile
Name
Veracyte IncSector
HealthcareIndustry
Diagnostics & ResearchPhone
(650) 243-6300Address
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS